The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
ONCOMING
The Internal Prospective validatiON of a prediCtiOn Model for the Change of admIssion for Patient With caNcer Admitted to the emerGency Department (ONCOMING Study)
1 other identifier
observational
200
1 country
1
Brief Summary
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2024
CompletedFirst Posted
Study publicly available on registry
August 16, 2024
CompletedStudy Start
First participant enrolled
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedAugust 15, 2025
August 1, 2025
12 months
August 14, 2024
August 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cancer Admission Score
Cancer Admission Score (CAS) calculated after triage and after first blood results, ranging from 0 to 100%. The higher the score the greater the change of admission
Through study completion, an average of 6 months
Disposition
The outcome of a visit to the ED, being either admission or home
Through study completion, an average of 6 months
Agreement between the CAS and the actual disposition
Agreement between the CAS predicted outcome and the actual outcome
Through study completion, an average of 6 months
Secondary Outcomes (4)
Agreement between expected disposition by nurse and actual disposition
Through study completion, an average of 6 months
time-to-disposition
Through study completion, an average of 6 months
time-to-leave
Through study completion, an average of 6 months
ED Length of Stay
Through study completion, an average of 6 months
Other Outcomes (7)
Sex
Through study completion, an average of 6 months
Age
Through study completion, an average of 6 months
Type of Cancer
Through study completion, an average of 6 months
- +4 more other outcomes
Study Arms (1)
Cancer patients
All adult patients with an active cancer diagnosis who visit the emergency department (ED) of the Erasmus University Medical Centre (Erasmus MC).
Interventions
A prediction model that calculates the chance for a patient to be admitted after triage and after first blood results
Eligibility Criteria
All adult patients with an active cancer diagnosis who visit the ED of the Erasmus University Medical Center (Erasmus MC).
You may qualify if:
- Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
- Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.
You may not qualify if:
- \<18 years old
- Only received a surgical intervention as cancer treatment
- Admitted to the ED for the surgical department
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erasmus University Medical Center
Rotterdam, South Holland, 3015GD, Netherlands
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jason den Duijn
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 14, 2024
First Posted
August 16, 2024
Study Start
December 2, 2024
Primary Completion
December 1, 2025
Study Completion
December 31, 2025
Last Updated
August 15, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share